Primary Prevention with Anticoagulation: The Compass Trial

Recorded On: 05/12/2019


Back to Package

  • Register
    • Non-member - $35
    • Member - $25
    • Resident/Fellow - $10
    • Student - $10

In this course the speaker will discuss the design, results and conclusions of The Compass Trial; review the previous and current literature regarding treatments for stable atherosclerotic vascular disease; discuss the use of anti-coagulation therapy in patients with stable atherosclerotic vascular disease. This lecture was recorded at the 2019 Exploring New Science in Cardiovascular Medicine course on May 12, 2019 in Baltimore, MD.

Chad Link, DO, FACOI

Assistant Clinical Professor

Michigan State University College of Osteopathic Medicine

Assistant Clinical Professor
Michigan State University College of Osteopathic Medicine

Cardiology Section Chairman
Sparrow TCI

Components visible upon registration.